ANTX
ANTX
NASDAQ · Pharmaceuticals

An2 Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$4.83
-0.13 (-2.62%)
As of Sep 22, 10:07 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +284.1% upside
Low Target $11.23
Average Target $18.55
High Target $22.80
Current Price $4.83
Current
$4.83
Target
$18.55
$11.23 $18.55 avg $22.80
Scenario Analysis
Bear Case
$11.23
132.5%
Low target
Base Case
$18.55
+284.1%
Avg target
Bull Case
$22.80
+372.0%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$7.19
-32.8% from high
52-Week Low
$1.00
+383.0% from low
Target vs 52W High
$18.55
+158.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +188.0%